Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2014.
|Second Quarter||Second Quarter|
|$ in millions, except EPS amounts||2014||2013|
Non-GAAP EPS that excludes items listed below 1
GAAP Net Income 2
|Non-GAAP Net Income that excludes items listed below 1,2||2,493||2,530|
Non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.85 exclude acquisition- and divestiture-related costs, restructuring costs and certain other items.